Background/Aims: Glomerular endothelium dysfunction leads to the progression of renal architectonic and functional abnormalities in early-stage diabetic nephropathy (DN). Advanced glycation end products (AGEs) and receptor for AGEs (RAGE) are proved to play important roles in diabetic nephropathy. This study investigated the role of Salvianolic acid A (SalA) on early-stage DN and its possible underlying mechanism. Methods: In vitro AGEs formation and breaking rate were measured to illustrate the effect of SalA on AGEs. Type 2 diabetic nephropathy rats were induced by high-fat diet and low-dose streptozocin (STZ). After eight-week treatment with SalA 1 mg/kg/day, 24h-urine protein, creatinine clearance was tested and renal structural injury was assessed by PAS and PASM staining. Primary glomerular endothelial cell permeability was evaluated after exposed to AGEs. AGEs-induced RhoA/ROCK and subsequently activated disarrange of cytoskeleton were assessed by western blot and immunofluorescence. Results: Biochemical assay and histological examination demonstrated that SalA markedly reduced endothelium loss and glomerular hyperfiltration, suppressed glomerular hypertrophy and mesangial matrix expansion, eventually reduced urinary albumin and ameliorated renal function. Further investigation suggested that SalA exerted its renoprotective effects through inhibiting AGE-RAGE signaling. It not only inhibited formation of AGEs and increased its breaking in vitro, but also reduced AGEs accumulation in vivo and downregulated RAGE expression. SalA restored glomerular endothelial permeability through suppressing AGEs-induced rearrangement of actin cytoskeleton via AGE-RAGE-RhoA/ ROCK pathway. Moreover, SalA attenuated oxidative stress induced by AGEs, subsequently alleviated inflammation and restored the disturbed autophagy in glomerular endothelial cell and diabetic rats via AGE-RAGE-Nox4 axis. Conclusion: Our study indicated that SalA restored glomerular endothelial function and alleviated renal structural deterioration through inhibiting
Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling

Introduction
Diabetic nephropathy (DN) is one of the most common complications of diabetes and the leading cause of end-stage renal disease. Glomerular hyperfiltration is notable in earlystage DN since it causes albuminuria and initiates the sclerotic process of glomeruli, resulting in fibrosis and irreversible renal failure [1, 2] . Growing evidence suggests that endothelial dysfunction is the central link in increasing permeability of glomerular filtration barrier [3] . Endothelial injury is manifested through loss of extracellular glycocalyx [4] , endothelial hyperpermeability [5] , disrupted secretion of endothelial-derived vasoactive mediators, and phenotype changes [6] .
The accumulation of AGEs plays a crucial part in the onset and progress of DN. AGEs exert effect through cross-link directly or by binding various receptors on cell surface such as receptor for AGEs (RAGE) indirectly [7] . These events stimulate the production of aroused reactive oxygen species (ROS) and ultimately lead to increased vascular permeability and inflammation. Reports showed that disarrangement of F-actin cytoskeleton induced by activation of RhoA/ROCK signaling is the main mechanism in AGEs-RAGE injured endothelial cell hyperpermeability [8] . Moreover, AGE-RAGE initiates the cascades of signaling transduction such as AGE-RAGE-NADPH oxidase (Nox) to aggravate oxidative stress [9] , or AGE-RAGE-Jak/Stat to interfere the biosynthesis of collagen in kidney fibroblast [10] . These downstream pathways are involved widely in inflammation, autophagy, and apoptosis exerting an extend influence on cellular metabolism. Thus, inhibition of the AGEs formation and/or the blockade of RAGE-downstream pathways have become a promising therapeutic strategy for DN.
Salvianolic acid A (SalA), ((2R)-3-(3, 4-dihydroxyphenyl)-2-[(E)-3-[2-[(E)-2-(3, 4-dihydroxyphenyl) ethenyl]-3, 4-dihydroxyphenyl]
prop-2-enoyl] oxypropanoic acid) is a water-soluble phenolic acid extracted from the dried root and rhizome of Salvia miltiorrhiza Bunge [11] . Studies demonstrated that SalA has various pharmacological effects such as anti-ischemia [12] , anti-inflammation [13] and anti-diabetic [14] . Especially, SalA displays a beneficial effect on diabetic complications, including hepatic fibrosis [15] , diabetic vascular endothelial dysfunction [16] and diabetic peripheral neuropathy [17] . All findings indicate that SalA has multiple protective effects on diabetic macrovascular and microvascular complications. In addition, Fan [18] reported that SalA exerted renal protection on doxorubicin-induced nephropathy through ameliorating podocyte injury and suppressing oxidative stress and inflammation. However, the effect of SalA on diabetic nephropathy, especially the glomerular endothelial hyperpermeability remains unknown yet. According to reviews of SalA on diabetic complications, we speculated that SalA could play a protective role in diabetic nephropathy.
In this study, we found that SalA protected against early-stage diabetic nephropathy by ameliorating glomerular endothelial hyperpermeability in type 2 diabetic rats. Furthermore, we first demonstrated that SalA played its renoprotective effects through AGE-RAGE-NADPH oxidase 4 (Nox4) and AGE-RAGE-RhoA/ROCK signaling pathway.
Materials and Methods
Reagents and Antibodies
SalA (HPLC, 98%) was provided as a lyophilized powder by the Institute of Materia Medica, Chinese Academy of Medical Sciences (Beijing, China). Streptozocin (STZ) was purchased from Sigma Chemical Co, USA. Advanced glycation end products (AGEs), was obtained from Bioss Chemical, China. All other chemicals are of analytical grade. The antibodies used in our study were as follows: rabbit anti-RAGE (Cat. ab3611), rabbit anti-Nox4 (Cat. ab109225), rabbit anti-Interleukin-6 (IL-6) (Cat. ab6672), rabbit anti-Tumor Necrosis Factor-α (TNF-α) (Cat. ab6671) (Abcam, USA), mouse anti-Aminopeptidase P (JG-12) (Cat. sc-65390), rabbit anti-Interleukin-1β (IL-1β) (Cat. sc-7884), mouse anti-Intercellular Adhesion Molecule 1 (ICAM-1) (Cat. sc-8439), mouse anti-Vascular Cell Adhesion Molecule-1 (VCAM-1) (Cat. sc13160) (Santa cruz, USA), rabbit anti-RhoA (Cat. 2117), rabbit anti-ROCK (Cat. 9029), rabbit anti-Phospho-Myosin Light Chain (p-MLC) (Cat. 3671), rabbit anti-Myosin Light Chain (t-MLC) (Cat. 3672), rabbit anti-p62/SQSTM1 (Cat. 5114), rabbit anti-LC3A/B (Cat. 12741), rabbit anti-Bclin-1 (Cat. 3495), rabbit anti-Sirt1 (Cat. 9475), rabbit anti-Forkhead Transcription Factors-3a (Foxo3a) (Cat. 12829s), rabbit anti-BCL2/Adenovirus E1B 19 kDa ProteinInteracting Protein 3 (Bnip3) (Cat. 12396s), rabbit anti-Atg5 (Cat. 12994), rabbit anti-Atg7 (Cat. 8558), rabbit anti-Atg12 (Cat. 4180) (CST, USA), mouse anti-β-Actin (Cat. 3010ES50) (Yeasen, China).
AGEs Measurement
Antiglycation activity of SalA in vitro was tested by the ability to inhibit the fluorescence of AGEs as described in previous study [19] with a minor modification. Briefly, a reaction mixture of 5 mg/ml bovine serum albumin (BSA) , 0.5 M glucose, 1% glyoxal, 0.1 mM PMSF, 100 U/ml penicillin and 100 U/ ml streptomycin in 0.1 M phosphate buffered-saline (PBS), pH 7.4 with different concentrations of SalA was incubated in darkness at 37 °C for 4 days. AGEs formation was assessed by fluorescent intensity at excitation wavelength of 355 nm and emission wavelength of 460 nm. The AGEs cross-link breaking activity of SalA was assessed by monitoring the fluorescent intensity change of AGEs after incubated with different concentrations of SalA for 4 days. The remained AGEs were estimated by fluorescent intensity at excitation wavelength of 355 nm and emission wavelength of 460 nm.
Animals Experimental Design
Male Sprague-Dawley (SD) rats (140-160 g) purchased from Beijing HFK Bioscience Co. Ltd (Beijing, China) were kept under a SPF environment (22-25 °C, humidity 60-70%, 12-h light/dark cycle) for one week to acclimate these conditions. All animals were handled in accordance with ethical guidelines for using and caring of laboratory animals with the permission of animal care committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences.
The rat model of diabetic nephropathy was induced as previously described [20] with a minor modification (Fig.1) . In brief, rats were fed with a high-fat and high-sucrose diet (standard diet supplemented with 10% sucrose, 10% lard stearin, 2% cholesterin, and 0.5% cholic acid) for four weeks. After fasted overnight, 35 mg/kg STZ was administered by a single intraperitoneal injection after dissolved with 0.1 M citrate buffer (pH 4.4), while normal control animals received only citrate buffer. Rats with fasting blood glucose (FBG) higher than 10 mM and lower than 25 mM were considered as diabetes, and then fed with HFD (10% lard stearin, 2% cholesterin and 0.5% cholic acid) for another eight weeks. Meanwhile, diabetic rats were randomly assigned into two groups: diabetic model rats (DM), and diabetic rats with orally administration of SalA at 1 mg/kg/day (SalA). Age-matched rats were served as normal control and were treated with vehicle and standard chow diet during the entire experiment. At the end of the eight-week treatment, rats were sacrificed after fasting overnight. Blood samples were collected and kidney tissue was immediately frozen in liquid nitrogen or fixed in 4% paraformaldehyde for histological diagnosis. The specific markers for oxidative stress including serum level of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) were analyzed by commercial kits (Jiancheng Biotech Co., Ltd., Nanjing, China). Serum level of nitric oxide (NO) was assayed by Griess reagent and renal cortex catalase (CAT) activity was performed using catalase assay kit following manufacturer's instruction (Beyotime Institute of Biotechnology, Shanghai, China). Serum level of 8-OHdG and concentration of AGEs in serum and renal cortex were conducted as the manufacturer's instructions using a commercially available kit (CUSABIO, Wuhan, China).
Urine sample collections were conducted referred to previous report [21] . At 8 th week, rats were held in metabolism cages for 24 hours with access to food and water. 24 h-urine volume was recorded and urinary albumin concentration was measured by ELISA assay (CUSABIO, Wuhan, China). Urinary creatinine concentrations were measured using a creatinine assay kit (Jiancheng Biotech Co., Ltd., Nanjing, China). Creatinine clearance (Ccr) was calculated using the following formula: Ccr (μl/min) = (Ucr/Pcr) × urine volume (μl/min), as P. Palsamy et al. reported [22] . Albumin creatinine ratio (UACR) was expressed as the ratio of total urinary albumin to creatinine, as previously described [23] .
Histopathology Analysis and Immunohistochemistry Staining Morphological Analysis
Kidney mesangial expansion was assessed referred to previous study [24] . Fifteen glomeruli randomly selected from each rat were measured. The Periodic Acid-Silver Methenamine (PASM)-positive material in the mesangial area and glomerular tuft area was calculated by Image J 4.5 software (NIH, USA). Periodic acid Schiff-stained was carried out to evaluate the glomerular volume [25] . Briefly, the mean glomerular tuft volume (GV) was determined of the mean glomerular cross-sectional area (GA) under optical microscopy. GA was estimated by the average area of a total of fifteen cortical glomeruli from each animal. GV was calculated as GV = β / κ × (GA)3/2, where β = 1.38, which is the shape coefficient for spheres (the idealized shape of glomeruli), and κ = 1.1, which is a size distribution coefficient. HE staining was conducted and renal interstitial inflammation was scored as previously reported [26] . Briefly, inflammation was scored on a range of 0 to 3. 0: normal renal interstitium without inflammation infiltration; 1: mild infiltration with little inflammatory cells scattered in renal interstitium; 2: medium infiltration with large inflammatory cells cluster accumulated in renal interstitium; 3: severe infiltration with necrosis and fibrotic lesions.
Immunohistochemical Staining
Renal sections were dewaxed in xylene and dehydrated in alcohol. After antigen retrieval by microwaving in citric saline at 95 °C for 3 min, sections were treated with 3% hydrogen peroxide for 25 min. The sections were blocked with 5% BSA and then incubated at 4 °C in a moist chamber overnight with primary antibody against mouse anti-Aminopeptidase P (JG-12) antibody (1:1000). Then sections were incubated with HRPconjugated goat anti-mouse IgG (DAKO, Wuhan, China) for 50 min at room temperature. JG-12 expressions were visualized by DAB (DAKO, Wuhan, China) staining. Sections were then examined under an optical microscope (Nikon ECLIPSE Ti-U, Nikon Corporation, Tokyo, Japan). Fifteen randomly selected glomeruli were digitally captured (400× magnification) and the optical density was quantified by Image J 4.5 image software (NIH, USA).
Cell Culture
Primary human renal glomerular endothelial cells (HRGECs) were purchased from ScienCell Research Laboratories (Carlsbad, CA, USA) and were cultured in endothelial cell medium supplemented with the endothelial cell growth factor containing 5% of fetal bovine serum (FBS) (Gibco, Australia) in humidified air at 37 °C with 5% CO 2 .
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Trans-endothelial Protein Passage and Trans-endothelial Electrical Resistance Measurement
HRGECs were seeded on collagen-coated supports (0.4 µm pore size, 0.33 cm 2 surface area) in transwell inserts (Corning Incorporated Life Sciences, USA) and cultured until confluent, as previously reported [27] . After exposed to AGEs (100 µg/ml) or AGEs (100 µg/ml) with SalA (0.3 µM or 3 µM) for 24 h, HRGECs trans-endothelial electrical resistance (TEER) was measured using Millipore Millicell ERS (Merck Millipore, USA) with probe MERSSTX01 and ERS-2 Epithelial volt-ohm meter as previously described [28] . Cell permeability was evaluated by passage of FITC-dextran (Sigma, USA). FITC-dextran 200 µl of 20 mg/ml in serum-free medium was added to the top chamber. One hour later, samples were removed from the top and bottom chamber and read in fluorometer (Molecular Devices Spectra Max M5, USA) at excitation 485 nm and emission 520 nm.
Cellular Reactive Oxygen Species Production Measurement
To assess the production of reactive oxygen species (ROS), HRGECs were incubated with AGEs (100 µg/ml) or AGEs (100 µg/ml) with SalA (0.3 µM or 3 µM) for 3 h, then cells (1 × 10 6 ) were stained with 10 μM 2',7'-dichlorofluorescin diacetate (DCFDA) for 30 min at 37 °C and were washed and resuspended in 0.1 M PBS, pH7.4. The oxidative conversion of DCFDA to DCFH-DA was measured by flow cytometry (C6, BD, USA).
F-actin Immunofluorescence Staining
HRGECs were treated with AGEs (100 µg/ml) or AGEs (100 µg/ml) with SalA (0.3 µM or 3 µM) for 24 h. F-actin distribution was assessed by staining with rhodamine-phalloidin 123 (RH123), followed by incubation with hoechst to stain the nuclear as previously described [29] . After staining, the cells were observed under a fluorescence microscope (Nikon ECLIPSE Ti-U, Nikon Corporation, Tokyo, Japan).
RNA extraction and quantitative real-time PCR
Total RNA was extracted using Trizol (Life Technologies, Grand Island, NY), followed by reverse transcription from 1 μg of total RNA to cDNA. cDNA was synthesized using a high capacity cDNA reverse transcription kit (Applied Biosystems, Foster city, CA). cDNA subsequently underwent quantitative realtime polymerase chain reaction (PCR) using the CFX96TM Real-time System (Bio-Rad, Singapore). The sequences of the primers are as follows: ACCCAAGATGTGGCCTTTAG and GTGACAACAGCGAGGTGTAA for VE-cadherin, CAGCTGGTCTTTACTCCATCG and CAGATTCTTAGCCTTCCCACTC for claudin-5, TGATGCCTTATGGCACTGGACTCA and CTGCTGCCTTTGTTGCTCTTCCAA for TBP.
Western Blot Analysis
Total cell or rat kidney cortex tissue lysates (20-50 μg) were subjected to SDS polyacrylamide gel. Electrophoresis and blotting were performed as described [30] . Signals were scanned and visualized by ChemiDoc-lTR 510 image system (Upland, CA, USA). The ratio of the protein interested was subjected to actin and was densitometrically analyzed by Image J software (NIH, MD).
Statistical analysis
All data are expressed as mean + SEM. One-way analysis of variance (ANOVA) with a post hoc Dunnett's test was used to determine statistically significant differences among groups. A value of P < 0.05 was considered as statistically significant.
Results
SalA inhibited AGEs formation and increased AGEs breaking
Basing on the established AGEs screening model in our lab, the effect of SalA on the formation and breaking of AGEs were tested. Incubation with SalA effectively broke the formed AGEs dose-dependently ( Fig. 2A) and exerted an inhibitory effect on AGEs formation (Fig. 2B) . 3A) and increase in food and water intake (Fig. 3B, 3C ). Treatment with SalA increased body weight by 11.7% compared with diabetic rats and reduced 24-h food intake without statistical significance, and reduced 24 h-water intake significantly. SalA decreased blood glucose from 4 th week till the end of experiment period (Fig. 3D) , consistent with lowering serum GSP at 8 th week (Fig. 3E) . Serum lipid profiles including TG, TCHO and LDL were increased in diabetic rats compared with normal rats. SalA treatment significantly decreased serum level 
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of TG, TCHO and LDL (Fig. 3F-3I ). Generally, SalA ameliorated the general diabetic conditions in type 2 diabetic rats.
SalA protected against diabetic nephropathy in type 2 diabetic rats
Compared with normal rats, diabetic rats showed significant increased kidney coefficient and 24 h-urine volume. SalA failed to impact kidney coefficient but markedly reduced 24 h-urine volume (Fig. 4A-4C ). In addition, SalA dramatically ameliorated the glomerular hyperfiltration and renal function, shown by reduction of 24 h-urinary microalbumin, serum BUN and Scr (Fig. 4D-4F) . Consistently, SalA administration increased creatinine clearance and blunted UACR elevation with statistically significance (Fig. 4G, 4H ).
In accordance with urinalysis and blood analysis, SalA treatment ameliorated the pathological deteriorations of glomerulus as implied by histological examination PAS staining. The results showed obvious glomerular hypertrophy with significant increase in glomerular size of diabetic rats. SalA treatment effectively prevented these histological changes (Fig. 4I,  4J ). The mesangial matrix accumulation was more extensive in the glomerulus of diabetic rats than normal rats exhibited by PASM staining, and 8-week treatment of SalA significantly reduced such expansion (Fig. 4K, 4L ).
SalA protected glomerular endothelium function through inhibiting AGE-RAGE signaling
Changes in endothelium expression patterns of experimental rats' glomerulus were examined by immunohistochemical staining of tissue sections with JG-12, a murine IgG1 monoclonal antibody specific for rat aminopeptidase P. As shown in JG-12 staining (Fig. 5A , (Fig. 5C-5E ).
In accordance with in vivo results, SalA alleviated higher permeability to FITC-dextran in AGEs-exposed monolayer of glomerular endothelial cells, as evidenced by lower ratio of fluorescence extracted from down chamber to up chamber in transwell assay (Fig. 5F ). In addition, decreased TEER value suggested that an impaired extracellular electronic barrier induced by AGEs was also ameliorated by SalA 0.3 µM and 3 µM (Fig. 5G) . Consistently, SalA downregulated RAGE expression in AGEs-injured HRGECs (Fig. 5H) . Collectively, these results indicated that SalA exerted endothelial protection through its inhibition of AGE-RAGE. 
SalA restored glomerular endothelial permeability through suppressing AGEs-induced rearrangement of actin cytoskeleton via AGE-RAGE-RhoA/ROCK pathway
We next focused on the endothelial morphological changes in cytoskeleton to elucidate the protective effects of SalA on restoration of glomerular endothelial permeability. F-actin staining of HRGECs revealed that, BSA control group showed less fiber string inside the cell with a slight ring around the cell periphery, however after exposed to AGEs 100 μg/ ml, the fiber string was stronger and became fascicle. Treatment with SalA 0.3 μM and 3 μM alleviated this alteration (Fig. 6A) .
Activation of RhoA-ROCK is the main mechanism involved in the AGEs-induced disarrangement of F-actin, so we examined the RhoA pathway by western blot. It suggested that RhoA and ROCK expression were upregulated after AGEs injury. Treatment with SalA 3 μM significantly suppressed the activated RhoA and ROCK expression. MLC is the downstream pathway of RhoA-ROCK and involved in rearranging cytoskeleton. The phosphorylation of MLC was also reduced by SalA 3 μM (Fig. 6B, 6C) . We next examined the expression of VEcadherin and claudin-5 in HRGECs, which is downregulated by RhoA-ROCK-MLC pathway, and are of vital importance in maintaining the normal permeability of endothelial cell. The results showed that in AGEs-exposed HRGECs, VE-cadherin and claudin-5 were markedly decreased while treatment with SalA could restore the cytoskeleton protein (Fig. 6D) . Collectively, SalA restored glomerular endothelial permeability through suppressing rearrangement of actin cytoskeleton via AGE-RAGE-RhoA/ROCK pathway.
SalA attenuated AGEs-induced oxidative stress in glomerular endothelial cell and diabetic rats via AGE-RAGE-Nox4 signaling
AGEs-induced ROS production is the main resource of oxidative stress, which we examined using DCFDA by flow cytometry. As displayed in Fig. 7A and 7B, AGEs significantly elevated ROS, while both SalA 0.3 µM and 3 µM scavenged ROS production induced by AGEs. NADPH oxidase played a central role in AGEs-injured HRGECs [9] , we found that Nox4 was highly expressed and SalA downregulated Nox4 expression (Fig. 7C) .
In accordance with in vitro results, SalA downregulated the Nox4 expression in diabetic kidney (Fig. 7D) . Moreover, SalA restored the reduced enzyme activity of CAT in diabetic kidney (Fig. 7E) . The effect of SalA on attenuating oxidative stress in diabetic rats was assessed by measuring serum levels of MDA, 8-OHdG and activity of SOD. As shown in Fig.  7F-7I , oxidative stress in diabetic model group is much more severe than normal group, administration of SalA restored the oxidative stress by lowering the level of MDA, 8-OHdG and NO, as well as enhanced serum SOD. In sum, SalA attenuated AGEs-induced oxidative stress in glomerular endothelial cell and diabetic rats via AGE-RAGE-Nox4 signaling.
SalA alleviated inflammation and restored the disturbed autophagy in diabetic rats
Since we observed a marked protection against AGEs-induced ROS production, we set out to assess whether SalA has effect on inflammation and autophagy in diabetic rats, as downstream of oxidative stress. The inflammation infiltration in kidney estimated by HE staining showed that diffused inflammatory cells clustered in interstitial tissue of kidney, SalA mildly reduced this inflammatory infiltration (Fig. 8A) . We then examined the protein expression of proinflammatory cytokines including TNF-α, IL-6, IL-1β, ICAM-1, and VCAM-1 in the kidney. The proinflammatory cytokines expression was significantly upregulated in diabetic kidneys, while SalA downregulated the proinflammatory cytokines compared with the diabetic model group (Fig. 8B) .
The release of proinflammatory cytokines combined with environment stress such as oxidative stress undergoes integration to ensure tissue homeostasis. Autophagy is a major contributor to maintain intracellular homeostasis. p62/Sqstm1, which is accumulated by disturbed autophagy lysosome pathway, was significantly increased in the kidneys of diabetic rat. Meanwhile, the ratio of LC3II to LC3I is lower accompanied with decreased Bclin-1. These results suggested that autophagy lysosome pathway was impaired during diabetic nephropathy progress. However, this impairment was restored by eight-week administration (Fig. 8C) . Previous studies have confirmed that Sirt1 exerts renal protective effects involved in regulating cellular homeostasis such as autophagy and inflammation. In our current study, Sirt1 expression was dramatically downregulated in diabetic nephropathy, and correspondingly a key mediator in Sirt1-Foxo3a-Bnip3 related regulation of autophagy. Treatment with SalA restored Sirt1 expression and upregulated its downstream mediator expression, and subsequently upregulated Atg5, Atg7, and Atg12 which were important in autophagosome formation (Fig. 8D) . Collectively, our findings indicated that SalA upregulated Sirt1-Foxo3a-Bnip3 pathway to ameliorate the impaired autophagy. 
Discussion
It is well known that AGEs and its receptor RAGE play important roles in vascular endothelial dysfunction, diabetic complications, especially in diabetic nephropathy. The endothelial protection of SalA proved previously [16] led us to detect its effects on glomerular endothelium and investigate its influence on AGE-RAGE signaling. Based on the previous findings of SalA on type 2 diabetic complications in our lab, we chose SalA 1mg/kg/day as the treatment dose in our current study. The present study first reported that SalA inhibited AGEs formation, and AGE-RAGE signaling as well. We demonstrated that SalA protected against early-stage diabetic nephropathy by attenuating glomerular hyperfiltration and kidney structure deterioration. Further mechanism investigation suggested that the protective effects of SalA on glomerular microvascular endothelial cell were involved in suppressing AGEs-activated RhoA-ROCK and subsequent phosphorylation of MLC-regulated disarrangement of cytoskeleton. More importantly, these beneficial effects of SalA were involved in attenuating AGE-RAGE-Nox4-induced oxidative stress, inflammation and enhancing autophagy of glomerular endothelial cell in type 2 diabetic rats.
Among all impact factors contributing to DN, AGEs-induced structural and functional damage in kidney is hyperglycemia-independent [31] . Thus, intensive blood-glucose control could barely prevent the progress of diabetic nephropathy [32] . Various types of AGEs formation inhibitors (e.g. aminoguanidine) or AGEs breakers (e.g. alagebrium) have shown the beneficial effects on diabetic nephropathy through decreasing collagen accumulation and subsequently inhibiting glomerulosclerosis injury to retard albumin excretion rate [33] . However, these compounds have been withdrawn from clinical trial because of its unsatisfactory safety [34] . In current study, we used SalA, a natural product from Salvia miltiorrhiza Bunge with the confirmed drug safety. The screening results showed the direct inhibitory effect of SalA on AGEs. Different from aminoguanidine, a nonspecific inhibitor via binding early glycation and glycoxidation products, SalA not only inhibited AGEs formation but also broke the formed AGEs dose-dependently. Our study confirmed that SalA suppressed AGEs accumulation in both serum and kidney tissue. Moreover, SalA reduced RAGE expression in AGEs-injured glomerular endothelial cells and kidney in diabetic rats, which is possibly owing to SalA's inhibitory effect on AGEs since AGEs can induce RAGE expression dose-dependently and time-dependently [35] .
Current therapeutic strategies for diabetic nephropathy are trying to slow the disease progression although unable to reverse the disease. In the present eight-week study, we observed the obvious glomerular hyperfiltration and albuminuria in diabetic rats, accompanied by markedly accentuated glomerular hypertrophy and mesangial matrix expansion, which is characteristic of early-stage diabetic nephropathy. Eight-week treatment with SalA effectively ameliorated the glomerular hyperfiltration and urinary microalbumin as well as suppressed the glomerular hypertrophy and mesangial matrix expansion, which suggested that an early therapeutic intervene might slow down the progression of diabetic nephropathy.
In Maricbilkan's research [36] , they found that initiating events of renal injury largely related with the damage, loss, and remodeling of microvascular in the diabetic kidney. We confirmed this significant loss of glomerular microvascular endothelium in diabetic rats evidenced by low JG-12 expression. SalA restored the endothelium loss toward normal level. AGEs-provoked disruption of tight junctions and disarrangement of the F-actin cytoskeleton contribute to endothelial hyperpermeability. In this study, the hyperpermeability and impaired extra cellular barrier induced by AGEs were ameliorated by SalA. RhoA/ROCKmediated disarrangement of actin cytoskeleton and alteration of cell contractility are involved in endothelial hyperpermeability in response to AGEs injury [29] . Activation of RhoA-ROCK-MLC will downregulate VE-cadherin and claudin-5, which is central in permeability changes in chiefly organizing endothelial barrier [37] . Previous studies demonstrated that activation of RhoA depends on the binding of AGEs to RAGE [38] . In this study, we observed F-actin disarrangement in AGEs-injured HRGECs and SalA downregulated the AGEs-activated Cellular Physiology and Biochemistry
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RhoA-ROCK, phosphorylation of MLC and subsequently restored VE-cadherin and claudin-5 expression, which may be the underlying mechanism that SalA restored the endothelial permeability subjected to AGEs injury. Oxidative stress is one of major pathogenesis contributing to diabetic complications including nephropathy. It has been proved that increased oxidative stress induced glomerular endothelial surface layer deterioration, resulting in exacerbation of glomerular permselectivity and development of albuminuria in Zucker fatty rat models [39] . NADPH oxidases play important role in glucose-induced generation of ROS [40] , however, AGEs increase the levels of ROS through activation of NADPH oxidase in a receptor-independent manner or through RAGE. Nox4, which is the most abundant NADPH oxidase homolog in kidney, is a major source of renal ROS [41] . Previous findings showed that SalA has a profound antioxidant effect on scavenging free radical [42] and activating antioxidase regulator such as Nrf2 [26] . In accordance with our previous study, we demonstrated SalA downregulated Nox4 expression aroused by AGEs and scavenged ROS production markedly in glomerular endothelial cell. Taken together, the protection of SalA on early-stage diabetic nephropathy may be largely due to its antioxidative effect by AGE-RAGE-Nox4 signaling pathway.
ROS is the most important mechanism for inflammatory response induction. Moreover, inflammation is also a vital mechanism leading to endothelial injury in diabetic context since it is often strongly linked to intensify oxidative stress-induced endothelial damage [22] . In this study, we found that SalA markedly reduced the production of proinflammatory cytokines such as IL-6 and TNF-α and inflammatory infiltration in diabetic kidney. It is possibly because SalA inhibited AGEs induced-ROS cascades and subsequently attenuated the inflammation. However, this hypothesis needs a further demonstration in our future work.
In response to inflammation and oxidative stress, autophagy is of vital importance in maintaining cellular homeostasis [43] . It has been reported that autophagy is impaired in diabetic nephropathy [44] and has become a promising target for treatment [45] . We reported that a disturbed autophagy-lysosome pathway is related with AGEs-evoked oxidative stress which triggered lysosomal membrane permeabilization and lysosomal dysfunction [46] . Very likely, we observed a decline of autophagy in diabetic kidney indicated by accumulation of p62/Sqstm1, decline of the ratio of LC3II/LC3I, and Beclin-1. SalA mildly restored diabetic autophagy after eight-week administration. Considering the interplay among inflammation, oxidative stress and autophagy we discussed above in diabetic nephropathy, this amelioration of SalA might be closely related to its attenuation of oxidative stress and inflammation response. Previous research has confirmed that Sirt1-facilitated autophagy induction in diabetic nephropathy might contribute to a renoprotective effect [47] . Sirt1 expression is downregulated in diabetic patient [48] . In addition, the expression and activity of Sirt1 is decreased in a dose-and time-dependent manner under AGEs injury [49] . In accordance with previous studies, we observed the downregulated Sirt1 expression in diabetic kidneys. SalA restored the Sirt1 expression and subsequently upregulated the expression of downstream Sirt1-Foxo3a-Bnip3 and key protein in autophagosome formation such as atg5, atg7 and atg12. Collectively, SalA inhibited AGEs induced-ROS cascades which contribute to a subsequently beneficial effect on attenuating the inflammation and restoring the disturbed autophagy.
Conclusion
Our current findings showed that SalA attenuated glomerular filtration dysfunction and protected against diabetic nephropathy by inhibiting AGE-RAGE signaling. Further investigation suggested that its protective effects on glomerular endothelial cell are involved in preventing AGEs-induced endothelial loss and stabilizing permeability as well as cell electrical barrier through suppressing AGE-RAGE-RhoA/ROCK mediated cytoskeleton rearrangement. Additionally, SalA exerted antioxidative effect, thereby ameliorated the inflammation and enhanced impaired autophagy by AGE-RAGE-Nox4 signaling pathway. In Fig. 9 . Schematic diagram showing that SalA ameliorated diabetic nephropathy through inhibiting AGE-RAGE system. AGEs interact with RAGE induces activation of RhoA/ROCK pathway, which results in cytoskeleton rearrangement and endothelial hyperpermeabilty. On the other hand, SalA attenuated oxidative stress through inhibition on AGE-RAGE-Nox4, which will subsequently suppress inflammation and an impaired autophagy in diabetic rats.
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